Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Frebourg

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Archives of Neurology|June 17, 1998
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer diseaseM Martinez, D Campion, A Brice, et al.
Cancer Research|December 15, 1996
Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancerJ L Mauillon, P Michel, J M Limacher, et al.
Molecular Psychiatry|October 26, 2002
The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficitG Raux, F Bonnet-Brilhault, S Louchart, et al.
European Journal of Human Genetics : EJHG|April 10, 1999
No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophreniaF Bonnet-Brilhault, C Laurent, D Campion, et al.
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Human Molecular Genetics|September 16, 1998
Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonismC Dumanchin, A Camuzat, D Campion, et al.
Psychiatry Research|June 1, 1996
Association study between schizophrenia and monoamine oxidase A and B DNA polymorphismsB Coron, D Campion, F Thibaut, et al.
Journal of Medical Genetics|August 1, 1996
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study GroupD Campion, A Brice, D Hannequin, et al.
Genes, Chromosomes & Cancer|October 2, 2001
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effectS Auroy, M F Avril, A Chompret, et al.
European Journal of Human Genetics : EJHG|September 12, 2000
APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French populationL Zurutuza, P Verpillat, G Raux, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Archives of Neurology|June 17, 1998
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer diseaseM Martinez, D Campion, A Brice, et al.
Cancer Research|December 15, 1996
Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancerJ L Mauillon, P Michel, J M Limacher, et al.
Molecular Psychiatry|October 26, 2002
The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficitG Raux, F Bonnet-Brilhault, S Louchart, et al.
European Journal of Human Genetics : EJHG|April 10, 1999
No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophreniaF Bonnet-Brilhault, C Laurent, D Campion, et al.
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Human Molecular Genetics|September 16, 1998
Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonismC Dumanchin, A Camuzat, D Campion, et al.
Psychiatry Research|June 1, 1996
Association study between schizophrenia and monoamine oxidase A and B DNA polymorphismsB Coron, D Campion, F Thibaut, et al.
Journal of Medical Genetics|August 1, 1996
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study GroupD Campion, A Brice, D Hannequin, et al.
Genes, Chromosomes & Cancer|October 2, 2001
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effectS Auroy, M F Avril, A Chompret, et al.
European Journal of Human Genetics : EJHG|September 12, 2000
APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French populationL Zurutuza, P Verpillat, G Raux, et al.
Pageof 11